ProShare Advisors LLC lessened its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) by 10.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,255 shares of the company's stock after selling 2,097 shares during the period. ProShare Advisors LLC's holdings in Pediatrix Medical Group were worth $405,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Brandes Investment Partners LP grew its holdings in Pediatrix Medical Group by 17.5% during the first quarter. Brandes Investment Partners LP now owns 137,207 shares of the company's stock valued at $3,222,000 after purchasing an additional 20,462 shares during the last quarter. Boston Partners grew its stake in shares of Pediatrix Medical Group by 72.3% in the first quarter. Boston Partners now owns 22,194 shares of the company's stock worth $521,000 after acquiring an additional 9,311 shares during the last quarter. Campbell & CO Investment Adviser LLC acquired a new stake in shares of Pediatrix Medical Group in the first quarter worth $421,000. Swiss National Bank grew its stake in shares of Pediatrix Medical Group by 7.4% in the first quarter. Swiss National Bank now owns 184,000 shares of the company's stock worth $4,320,000 after acquiring an additional 12,600 shares during the last quarter. Finally, Duality Advisers LP acquired a new stake in shares of Pediatrix Medical Group in the first quarter worth $622,000. Institutional investors and hedge funds own 95.98% of the company's stock.
Get
Pediatrix Medical Group alerts:
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on MD shares. BMO Capital Markets lowered their price objective on shares of Pediatrix Medical Group from $25.00 to $23.00 and set a "market perform" rating on the stock in a research note on Wednesday, August 10th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Pediatrix Medical Group from $24.00 to $16.00 in a research note on Tuesday, May 10th. Finally, Credit Suisse Group lowered their price objective on shares of Pediatrix Medical Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a research note on Thursday, August 11th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $24.67.
Pediatrix Medical Group Stock Down 1.4 %
MD opened at $17.45 on Friday. Pediatrix Medical Group, Inc. has a fifty-two week low of $17.17 and a fifty-two week high of $31.72. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.39 and a quick ratio of 1.39. The firm's fifty day moving average price is $21.35 and its two-hundred day moving average price is $21.47. The company has a market capitalization of $1.47 billion, a P/E ratio of 17.81, a P/E/G ratio of 1.13 and a beta of 1.84.
Pediatrix Medical Group (NYSE:MD – Get Rating) last posted its quarterly earnings results on Thursday, August 4th. The company reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.04. The firm had revenue of $486.00 million for the quarter, compared to the consensus estimate of $491.54 million. Pediatrix Medical Group had a net margin of 4.30% and a return on equity of 16.15%. The business's revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.36 earnings per share. On average, analysts anticipate that Pediatrix Medical Group, Inc. will post 1.71 EPS for the current year.
Pediatrix Medical Group Company Profile
(Get Rating)
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
See Also
- Get a free copy of the StockNews.com research report on Pediatrix Medical Group (MD)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
